Introduction
Nasal polyps are caused by a chronic inflammatory process in the lining of the nose and sinuses that leads to soft, grape-like tissue growths. They do not form because of a single event; instead, they develop when long-term irritation alters the normal balance of the nasal mucosa, allowing fluid buildup, immune cell activation, and tissue remodeling. The main factors involved include persistent inflammation, allergy-like immune responses, repeated sinus disease, genetic susceptibility, and certain underlying conditions such as asthma or aspirin-exacerbated respiratory disease.
To understand why nasal polyps form, it helps to first examine how the nasal and sinus lining normally works. Healthy mucosa acts as a protective barrier, producing mucus to trap particles and using tiny cilia to move that mucus out of the sinuses. When this system is repeatedly inflamed, the tissue becomes swollen, more permeable, and less efficient at clearing mucus. Over time, this creates the biological environment in which polyps can develop.
Biological Mechanisms Behind the Condition
The mucosa lining the nose and paranasal sinuses is designed to filter air, humidify inhaled gas, and remove debris and microbes. It does this through a coordinated process involving mucus production, ciliary clearance, and immune surveillance. In nasal polyps, this normally ordered system becomes chronically disturbed. The lining is exposed to inflammatory signals for long periods, and the tissue responds by becoming edematous, meaning it absorbs fluid and swells.
A central feature of polyp formation is chronic inflammation of the sinonasal mucosa. In many people, this inflammation is dominated by eosinophils, mast cells, and other immune cells that release cytokines, histamine, and enzymes. These substances damage the epithelial barrier and make blood vessels more leaky. Fluid then accumulates in the tissue, and the connective tissue beneath the surface becomes loose and expanded. The result is a soft, pale outgrowth that protrudes into the nasal cavity.
Another important mechanism is disruption of the epithelial barrier itself. The surface lining is supposed to keep allergens, pathogens, and irritants at bay. When that barrier is injured repeatedly, more foreign material enters the tissue and stimulates additional immune activity. This creates a self-reinforcing cycle: inflammation weakens the barrier, a weakened barrier allows more exposure, and more exposure drives further inflammation. At the same time, impaired mucus clearance means inflammatory material remains in contact with the lining for longer periods, intensifying the process.
Tissue remodeling also contributes. Chronic inflammatory signaling changes the structure of the underlying connective tissue and blood vessels. Fibroblasts, which help maintain the tissue framework, may produce excess extracellular matrix in an abnormal pattern. In addition, the small blood vessels can become dilated and leaky, which promotes edema. These changes do not merely cause swelling; they alter the physical architecture of the mucosa, allowing polyp tissue to protrude and persist.
Primary Causes of Nasal polyps
The strongest cause of nasal polyps is chronic inflammation of the nose and sinuses, especially when that inflammation persists for months or years. This inflammation can arise from several closely related biological processes, but the end result is similar: the mucosal lining becomes swollen, immune-active, and structurally altered.
Chronic rhinosinusitis is the most direct and common underlying driver. In this condition, the sinus mucosa remains inflamed for a prolonged period. The inflammation may be associated with infection, allergy, or no obvious trigger at all. Over time, the irritated lining becomes thickened and edematous. The accumulation of fluid in the submucosal tissue creates outward bulging of the mucosa, which can eventually form a polyp. In many patients, nasal polyps are considered a physical expression of this chronic inflammatory state.
Type 2 inflammatory responses are another major cause. In many cases, the immune system reacts in a pattern similar to allergic disease, with cytokines such as interleukin-4, interleukin-5, and interleukin-13 promoting eosinophilic inflammation. Eosinophils release toxic proteins and inflammatory mediators that injure the mucosa and sustain tissue swelling. This immune pattern is especially important because it tends to be persistent and difficult for the mucosa to resolve on its own. It is one reason some people develop large, recurrent polyps.
Allergic inflammation can also contribute. When the nasal passages are repeatedly exposed to allergens such as pollen, dust mites, or animal dander, mast cells and other immune cells react by releasing histamine and other mediators. This causes congestion, mucus production, and swelling. Although allergies do not cause every case of nasal polyps, repeated allergic inflammation can create the prolonged mucosal irritation needed for polyp growth.
Asthma-related airway inflammation is closely linked to polyp formation in many individuals. The upper and lower airways share similar mucosal immune patterns, so inflammatory disease in the bronchi often parallels disease in the sinuses. The same cytokines, eosinophils, and epithelial changes that affect the lungs may also affect the nasal lining. This shared airway biology helps explain why nasal polyps and asthma commonly occur together.
Aspirin-exacerbated respiratory disease, also known as AERD, is another important cause. In this condition, sensitivity to aspirin or other nonsteroidal anti-inflammatory drugs is associated with chronic sinus inflammation, asthma, and recurrent nasal polyps. The mechanism involves abnormal metabolism of arachidonic acid, which shifts inflammatory signaling toward leukotrienes and away from protective prostaglandins. Leukotrienes promote swelling, mucus production, and eosinophilic inflammation, making the sinus tissue especially prone to polyp formation.
Contributing Risk Factors
Several additional factors increase the likelihood of developing nasal polyps by making the nasal environment more inflamed or less able to recover from injury. These are not always direct causes on their own, but they can strongly influence the biological conditions under which polyps arise.
Genetic influences are important because they affect immune behavior, epithelial barrier function, and the tendency to develop chronic inflammation. Some people inherit immune responses that are more easily driven toward eosinophilic or allergic inflammation. Others may have inherited differences in mucus regulation, ciliary function, or epithelial repair. These traits can make the nasal lining more vulnerable to persistent swelling and remodeling.
Environmental exposures also matter. Air pollution, tobacco smoke, occupational irritants, and frequent exposure to airborne particles can inflame the mucosa and damage its protective surface. These exposures may impair ciliary activity and increase oxidative stress, which weakens the tissue’s ability to clear mucus and recover from irritation. Over time, this chronic exposure can support the inflammatory conditions needed for polyp development.
Recurrent infections, particularly repeated sinus infections, can contribute by keeping the mucosa in an activated state. Infectious organisms stimulate immune responses, and the resulting inflammation can persist even after the acute infection improves. If infections become frequent or prolonged, the tissue may remain swollen and structurally altered long enough for polyps to form. Some people also have impaired sinus drainage, which makes infections more likely and prolongs inflammatory exposure.
Hormonal changes may influence susceptibility indirectly by affecting immune regulation and tissue fluid balance. While hormones are not usually considered a primary cause of nasal polyps, shifts in endocrine function can alter mucosal responsiveness and inflammatory activity. In some people, these changes may affect how strongly the nasal lining reacts to allergens or irritants.
Lifestyle factors, especially smoking and poor control of chronic airway inflammation, can worsen mucosal injury. Smoking exposes the nose and sinuses to toxins that impair ciliary motion and damage epithelial cells. When the mucosa cannot clear debris efficiently, inflammation tends to persist. In this sense, lifestyle factors do not create polyps directly, but they help maintain the biological conditions that favor them.
How Multiple Factors May Interact
Nasal polyps usually do not result from one isolated mechanism. More often, they arise when several biological processes overlap. A person may have a genetic tendency toward eosinophilic inflammation, then develop chronic sinus irritation from allergies or recurrent infections, and later experience further damage from environmental exposure. These factors reinforce one another rather than acting independently.
For example, chronic inflammation can weaken the epithelial barrier, and a weakened barrier allows allergens and microbes to penetrate more easily. That deeper exposure drives more immune activation, which increases swelling and tissue permeability. As the mucosa becomes more edematous, drainage worsens, creating a stagnant environment in which additional inflammation can persist. This feedback loop explains why nasal polyps often develop gradually and why they may recur if the underlying inflammatory pattern remains active.
The interaction between the upper and lower airways is also significant. Inflammatory disease in the sinuses can mirror inflammatory disease in the bronchi, and vice versa. When the immune system is already biased toward type 2 inflammation, multiple parts of the respiratory tract may be affected at once. This shared biology helps explain why polyps are common in people with asthma and certain aspirin-related respiratory reactions.
Variations in Causes Between Individuals
The cause of nasal polyps differs from person to person because the underlying biology is not identical in every case. Some individuals develop polyps primarily from allergic inflammation, while others have disease driven more by chronic infection, immune dysregulation, or aspirin sensitivity. The same visible growth can therefore reflect different upstream processes.
Genetics partly explains this variation. People inherit different immune set points, patterns of cytokine activity, and barrier properties in the mucosa. These inherited differences influence whether the nasal lining responds to irritation with a short-lived reaction or a long-lasting inflammatory cascade.
Age also matters. Nasal polyps are more often recognized in adults than in children, in part because chronic inflammatory conditions accumulate over time. Longer exposure to allergens, infections, pollutants, or airway disease increases the chance that the mucosa will undergo the structural changes needed for polyps to appear.
Overall health status can shift the picture as well. People with asthma, autoimmune tendencies, aspirin sensitivity, or chronic inflammatory disorders are more likely to develop polyp-forming mucosal inflammation. Their immune systems may already be primed toward persistent activation, making the nasal tissues less able to return to a healthy baseline after injury.
Environmental exposure influences which triggers are most relevant. Someone living with high air pollution or smoking exposure may develop polyps through chronic irritant injury, while another person may develop them mainly through allergic sensitization or repeated sinus infections. In practice, the cause is often a blend of inherited vulnerability and environmental burden.
Conditions or Disorders That Can Lead to Nasal polyps
Several medical conditions are strongly associated with nasal polyps because they create the chronic inflammatory environment required for their formation.
Chronic rhinosinusitis is the most direct associated disorder. It involves prolonged inflammation of the sinuses and nasal passages, often with thick mucus, poor drainage, and persistent mucosal swelling. When this state continues, the tissue can protrude into the nasal cavity as polyps.
Asthma is another closely linked disorder. The inflammatory patterns seen in asthma often overlap with those in the sinuses, particularly when eosinophils and type 2 cytokines are involved. This shared immune profile suggests a common airway disease process rather than two unrelated conditions.
Aspirin-exacerbated respiratory disease is especially important because it combines asthma, chronic sinus inflammation, and polyp formation. The abnormal handling of lipid mediators in this disorder promotes persistent upper airway inflammation and recurrent growth of polyp tissue.
Allergic rhinitis can also contribute when it is severe or long-lasting. Repeated allergen exposure keeps the nasal mucosa inflamed and swollen, increasing the chance that tissue remodeling and edema will progress to polyp formation.
Less commonly, structural problems that impair sinus drainage can help sustain inflammation by trapping mucus and limiting clearance. When the sinuses cannot ventilate and drain properly, inflammatory material remains in contact with the mucosa longer, which encourages the persistent swelling that underlies polyps.
Conclusion
Nasal polyps develop because the nasal and sinus lining enters a state of chronic inflammation that leads to swelling, immune-cell infiltration, barrier disruption, and tissue remodeling. The most important causes are chronic rhinosinusitis, type 2 inflammatory responses, allergies, asthma-related airway disease, and aspirin-exacerbated respiratory disease. These processes work by keeping the mucosa irritated, fluid-rich, and structurally altered until soft polyp tissue forms.
Risk factors such as genetics, environmental irritants, infections, and certain lifestyle exposures influence how strongly the mucosa responds to injury and how well it can recover. In many people, several factors overlap, producing a self-sustaining inflammatory cycle. Understanding these mechanisms makes it clear that nasal polyps are not random growths, but the visible result of a specific and prolonged biological response within the sinonasal tissues.